Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02614794 · FLOW

Participant flow

A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer · Source last updated 2023-08-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Tucatinib in combination with capecitabine \& trastuzumab
    id
    FG000
    title
    Tuc+Cap+Tra
  2. description
    Placebo in combination with capecitabine \& trastuzumab
    id
    FG001
    title
    Pbo+Cap+Tra
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        258
      2. group Id
        FG001
        num Subjects
        151
      type
      Death
    2. reasons
      1. group Id
        FG000
        num Subjects
        119
      2. group Id
        FG001
        num Subjects
        45
      type
      Study closure by Sponsor
    3. reasons
      1. group Id
        FG000
        num Subjects
        24
      2. group Id
        FG001
        num Subjects
        5
      type
      Withdrawal by Subject
    4. reasons
      1. group Id
        FG000
        num Subjects
        7
      2. group Id
        FG001
        num Subjects
        0
      type
      Lost to Follow-up
    5. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        1
      type
      Physician Decision
    6. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      Hospital closure
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        410
      2. group Id
        FG001
        num Subjects
        202
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        410
      2. group Id
        FG001
        num Subjects
        202
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Tucatinib in combination with capecitabine \& trastuzumab
    id
    FG000
    title
    Tuc+Cap+Tra
  2. description
    Placebo in combination with capecitabine \& trastuzumab
    id
    FG001
    title
    Pbo+Cap+Tra
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        258
      2. group Id
        FG001
        num Subjects
        151
      type
      Death
    2. reasons
      1. group Id
        FG000
        num Subjects
        119
      2. group Id
        FG001
        num Subjects
        45
      type
      Study closure by Sponsor
    3. reasons
      1. group Id
        FG000
        num Subjects
        24
      2. group Id
        FG001
        num Subjects
        5
      type
      Withdrawal by Subject
    4. reasons
      1. group Id
        FG000
        num Subjects
        7
      2. group Id
        FG001
        num Subjects
        0
      type
      Lost to Follow-up
    5. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        1
      type
      Physician Decision
    6. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      Hospital closure
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        410
      2. group Id
        FG001
        num Subjects
        202
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        410
      2. group Id
        FG001
        num Subjects
        202
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice